. Author manuscript; available in PMC: 2023 Aug 15.

Published in final edited form as: J Neurol Sci. 2022 Jun 10;439:120319. doi: 10.1016/j.jns.2022.120319

Table 2.

Regions involved among 210 subjects diagnosed with focal BSP.

Regions affected	Number of participants (%)
Regions affected	Based on exam checklist	Based on GDRS scores
Focal BSP with only upper face involvement	172 (81.9)	152 (72.4)
Focal BSP with upper face and at least one other body region	34 (16.2)	52 (24.8)
UF+LF	26 (12.4)	37 (17.6)
UF+NE	21 (10.0)	27 (12.9)
UF+L	6 (2.9)	6 (2.9)
UF+SH/PA	7 (3.3)	4 (1.9)
UF+H/DA/EL	1 (0.5)	5 (2.4)
UF+UL/PE	1 (0.5)	1 (0.5)
UF+FT/DL	1 (0.5)	1 (0.5)
UF+TR	1 (0.5)	2 (1.0)
UF+J+T	0 (0.0)	3 (1.4)

UF: upper face, LF: lower face, NE: neck, L: larynx, SH: shoulder, PA: proximal arm, H: hand, DA: distal arm, EL: elbow, UL: upper leg, PE: pelvis, FT: foot, DL: distal leg, TR: trunk, J: jaw, T: toungue